Reduced levels of CYP46A1 have been associated with other protein misfolding diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD) as well as other neurodegenerative diseases e.g. Niemann-Pick disease type C (NPC) [17–21]. This evidence concerns the gene CYP46A1 and Alzheimer disease.